5382-16-1,MFCD00005999
Catalog No.:AA0033ZQ

5382-16-1 | Piperidin-4-ol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5g
98%
in stock  
$10.00   $7.00
- +
10g
98%
in stock  
$13.00   $9.00
- +
25g
98%
in stock  
$16.00   $11.00
- +
100g
98%
in stock  
$26.00   $18.00
- +
500g
98%
in stock  
$89.00   $62.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0033ZQ
Chemical Name:
Piperidin-4-ol
CAS Number:
5382-16-1
Molecular Formula:
C5H11NO
Molecular Weight:
101.1469
MDL Number:
MFCD00005999
SMILES:
OC1CCNCC1
NSC Number:
62083
Properties
Properties
 
BP:
222°C at 760 mmHg  
Form:
Solid  
MP:
86-90 °C  
Refractive Index:
1.4400 (estimate)  
Stability:
Hygroscopic  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
50  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
XLogP3:
-0.3  

Downstream Synthesis Route

[1]JournalofMedicinalChemistry,1980,vol.23,p.1358-1363

[1]ChemicalandPharmaceuticalBulletin,1984,vol.32,p.4907-4913

[2]Patent:US4382892,1983,A

[1]Patent:EP1988077,2008,A1.Locationinpatent:Page/Pagecolumn64

[2]Patent:WO2012/59932,2012,A1.Locationinpatent:Page/Pagecolumn112

[3]Patent:CN106905245,2017,A.Locationinpatent:Paragraph0277;0278;0279;0280

[4]Patent:US2019/106436,2019,A1.Locationinpatent:Paragraph0513-0515

[5]Synthesis,1981,p.606-608

[6]Patent:EP1775298,2007,A1.Locationinpatent:Page/Pagecolumn38-39

[7]Patent:US2007/32478,2007,A1.Locationinpatent:Page/Pagecolumn147

[8]JournalofPhysicalChemistryB,2000,vol.104,p.10191-10195

[9]Patent:US2009/54425,2009,A1.Locationinpatent:Page/Pagecolumn24

[10]Patent:WO2009/131687,2009,A2.Locationinpatent:Page/Pagecolumn133

[11]Patent:US2014/121200,2014,A1.Locationinpatent:Paragraph0356;0357

[12]Patent:WO2014/183300,2014,A1.Locationinpatent:Page/Pagecolumn30

[13]Patent:KR2016/8881,2016,A.Locationinpatent:Paragraph0120;0121;0122;0123

[14]EuropeanJournalofMedicinalChemistry,2019,vol.163,p.690-709

[1]Synlett,1998,p.383-384

[2]SyntheticCommunications,2000,vol.30,p.1359-1364

[3]Patent:EP2218719,2010,A1.Locationinpatent:Page/Pagecolumn7-8

[1]Patent:WO2006/34473,2006,A2.Locationinpatent:Page/Pagecolumn220-221

[2]Patent:WO2006/34473,2006,A2.Locationinpatent:Page/Pagecolumn222

Literature

Title: Synthesis of novel IP agonists via N-aminoethyl cyclic amines prepared by decarboxylative ring-opening reactions.

Journal: Molecules (Basel, Switzerland) 20120131

Title: 4-(4-Chloro-phen-yl)-4-hy-droxy-piperidinium 2-(2-phenyl-eth-yl)benzoate.

Journal: Acta crystallographica. Section E, Structure reports online 20110701

Title: A Baeyer-Villiger oxidation specifically catalyzed by human flavin-containing monooxygenase 5.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20110101

Title: 2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.

Journal: Bioorganic & medicinal chemistry letters 20110101

Title: Investigation of 4-piperidinols as novel H3 antagonists.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: 4-(4-Chloro-phen-yl)-4-hy-droxy-piperidinium maleate maleic acid solvate.

Journal: Acta crystallographica. Section E, Structure reports online 20100801

Title: The spectroscopic (FT-IR, FT-IR gas phase, FT-Raman and UV) and NBO analysis of 4-Hydroxypiperidine by density functional method.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100301

Title: 4-(4-Chloro-phen-yl)-1-[3-(4-fluoro-benzo-yl)prop-yl]-4-hydroxy-piperidin-1-ium 2,4,6-trinitro-phenolate (haloperidol picrate).

Journal: Acta crystallographica. Section E, Structure reports online 20091001

Title: Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.

Journal: Bioorganic & medicinal chemistry 20080815

Title: Erratum: Poly[μ(2)-chlorido-nona-methyl-μ(3)-nitrato-tritin(IV)]. Corrigendum.

Journal: Acta crystallographica. Section E, Structure reports online 20080701

Title: CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.

Journal: Bioorganic & medicinal chemistry letters 20070401

Title: Organosilicon-containing thiazole derivatives as potential lipoxygenase inhibitors and anti-inflammatory agents.

Journal: Bioinorganic chemistry and applications 20070101

Title: Improved synthesis and radiolabeling of [11C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET.

Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20060201

Title: Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20030215

Title: The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency.

Journal: European journal of medicinal chemistry 20020601

Title: New mu-opioid receptor agonists with phenoxyacetic acid moiety.

Journal: Chemical & pharmaceutical bulletin 20020201

Title: Cytotoxic and anticancer properties of some 4-aryl-3-arylcarbonyl-1-ethyl-4-piperidinols and related compounds.

Journal: Die Pharmazie 20010501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:5382-16-1 Molecular Formula|5382-16-1 MDL|5382-16-1 SMILES|5382-16-1 Piperidin-4-ol
Catalog No.: AA0033ZQ
5382-16-1,MFCD00005999
5382-16-1 | Piperidin-4-ol
Pack Size: 5g
Purity: 98%
in stock
$10.00 $7.00
Pack Size: 10g
Purity: 98%
in stock
$13.00 $9.00
Pack Size: 25g
Purity: 98%
in stock
$16.00 $11.00
Pack Size: 100g
Purity: 98%
in stock
$26.00 $18.00
Pack Size: 500g
Purity: 98%
in stock
$89.00 $62.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0033ZQ
Chemical Name: Piperidin-4-ol
CAS Number: 5382-16-1
Molecular Formula: C5H11NO
Molecular Weight: 101.1469
MDL Number: MFCD00005999
SMILES: OC1CCNCC1
NSC Number: 62083
Properties
BP: 222°C at 760 mmHg  
Form: Solid  
MP: 86-90 °C  
Refractive Index: 1.4400 (estimate)  
Stability: Hygroscopic  
Storage: Inert atmosphere;Room Temperature;  
Complexity: 50  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 7  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 2  
XLogP3: -0.3  
Downstream Synthesis Route
5382-16-1    68077-26-9    75001-74-0 

[1]JournalofMedicinalChemistry,1980,vol.23,p.1358-1363

5382-16-1    82419-35-0    82419-37-2 

[1]ChemicalandPharmaceuticalBulletin,1984,vol.32,p.4907-4913

[2]Patent:US4382892,1983,A

5382-16-1    350-46-9    79421-45-7 

[1]Patent:EP1988077,2008,A1.Locationinpatent:Page/Pagecolumn64

[2]Patent:WO2012/59932,2012,A1.Locationinpatent:Page/Pagecolumn112

[3]Patent:CN106905245,2017,A.Locationinpatent:Paragraph0277;0278;0279;0280

[4]Patent:US2019/106436,2019,A1.Locationinpatent:Paragraph0513-0515

[5]Synthesis,1981,p.606-608

[6]Patent:EP1775298,2007,A1.Locationinpatent:Page/Pagecolumn38-39

[7]Patent:US2007/32478,2007,A1.Locationinpatent:Page/Pagecolumn147

[8]JournalofPhysicalChemistryB,2000,vol.104,p.10191-10195

[9]Patent:US2009/54425,2009,A1.Locationinpatent:Page/Pagecolumn24

[10]Patent:WO2009/131687,2009,A2.Locationinpatent:Page/Pagecolumn133

[11]Patent:US2014/121200,2014,A1.Locationinpatent:Paragraph0356;0357

[12]Patent:WO2014/183300,2014,A1.Locationinpatent:Page/Pagecolumn30

[13]Patent:KR2016/8881,2016,A.Locationinpatent:Paragraph0120;0121;0122;0123

[14]EuropeanJournalofMedicinalChemistry,2019,vol.163,p.690-709

5382-16-1    4701-17-1    207290-72-0 

[1]Synlett,1998,p.383-384

[2]SyntheticCommunications,2000,vol.30,p.1359-1364

[3]Patent:EP2218719,2010,A1.Locationinpatent:Page/Pagecolumn7-8

5382-16-1    26032-72-4    881194-69-0    881194-89-4 

[1]Patent:WO2006/34473,2006,A2.Locationinpatent:Page/Pagecolumn220-221

[2]Patent:WO2006/34473,2006,A2.Locationinpatent:Page/Pagecolumn222

Literature fold

Title: Synthesis of novel IP agonists via N-aminoethyl cyclic amines prepared by decarboxylative ring-opening reactions.

Journal: Molecules (Basel, Switzerland)20120131

Title: 4-(4-Chloro-phen-yl)-4-hy-droxy-piperidinium 2-(2-phenyl-eth-yl)benzoate.

Journal: Acta crystallographica. Section E, Structure reports online20110701

Title: A Baeyer-Villiger oxidation specifically catalyzed by human flavin-containing monooxygenase 5.

Journal: Drug metabolism and disposition: the biological fate of chemicals20110101

Title: 2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.

Journal: Bioorganic & medicinal chemistry letters20110101

Title: Investigation of 4-piperidinols as novel H3 antagonists.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: 4-(4-Chloro-phen-yl)-4-hy-droxy-piperidinium maleate maleic acid solvate.

Journal: Acta crystallographica. Section E, Structure reports online20100801

Title: The spectroscopic (FT-IR, FT-IR gas phase, FT-Raman and UV) and NBO analysis of 4-Hydroxypiperidine by density functional method.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy20100301

Title: 4-(4-Chloro-phen-yl)-1-[3-(4-fluoro-benzo-yl)prop-yl]-4-hydroxy-piperidin-1-ium 2,4,6-trinitro-phenolate (haloperidol picrate).

Journal: Acta crystallographica. Section E, Structure reports online20091001

Title: Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.

Journal: Bioorganic & medicinal chemistry20080815

Title: Erratum: Poly[μ(2)-chlorido-nona-methyl-μ(3)-nitrato-tritin(IV)]. Corrigendum.

Journal: Acta crystallographica. Section E, Structure reports online20080701

Title: CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.

Journal: Bioorganic & medicinal chemistry letters20070401

Title: Organosilicon-containing thiazole derivatives as potential lipoxygenase inhibitors and anti-inflammatory agents.

Journal: Bioinorganic chemistry and applications20070101

Title: Improved synthesis and radiolabeling of [11C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET.

Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine20060201

Title: Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.

Journal: Journal of immunology (Baltimore, Md. : 1950)20030215

Title: The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency.

Journal: European journal of medicinal chemistry20020601

Title: New mu-opioid receptor agonists with phenoxyacetic acid moiety.

Journal: Chemical & pharmaceutical bulletin20020201

Title: Cytotoxic and anticancer properties of some 4-aryl-3-arylcarbonyl-1-ethyl-4-piperidinols and related compounds.

Journal: Die Pharmazie20010501

Building Blocks More >
2909-79-7
2909-79-7
4-tert-Butyl-n,n-dimethylaniline
AA00342M | MFCD00008833
877-03-2
877-03-2
5-Bromo-1H-indole-3-carbaldehyde
AA00345K | MFCD00152016
109299-78-7
109299-78-7
Pyrimidine-5-boronic acid
AA00348D | MFCD03002366
90562-34-8
90562-34-8
7-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride
AA0034BD | MFCD08061330
610791-05-4
610791-05-4
Methyl 1-Boc-azetidine-3-carboxylate
AA0034EL | MFCD06656775
111300-06-2
111300-06-2
trans-N-4-Boc-aminocyclohexanol
AA0034HF | MFCD03844613
766-05-2
766-05-2
Cyclohexanecarbonitrile
AA0034KO | MFCD00040444
87-13-8
87-13-8
Diethyl ethoxymethylenemalonate
AA0034NI | MFCD00009148
5571-36-8
5571-36-8
Estradiene dione-3-keta
AA0034QP | MFCD08062585
3770-50-1
3770-50-1
Ethyl indole-2-carboxylate
AA0034TI | MFCD00005609
Submit
© 2017 AA BLOCKS, INC. All rights reserved.